| Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology BY Gajera, DA Shah, RH Dave International Journal of Pharmaceutics 559, 348-359, 2019 | 58 | 2019 |
| Fusion method for solubility and dissolution rate enhancement of ibuprofen using block copolymer poloxamer 407 RP Dugar, BY Gajera, RH Dave AAPS PharmSciTech 17, 1428-1440, 2016 | 51 | 2016 |
| Investigate the effect of solvents on wet granulation of microcrystalline cellulose using hydroxypropyl methylcellulose as a binder and evaluation of rheological and thermal … D Tank, K Karan, BY Gajera, RH Dave Saudi pharmaceutical journal 26 (4), 593-602, 2018 | 38 | 2018 |
| A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient … PJ Patel, BY Gajera, RH Dave Drug development and industrial pharmacy 44 (12), 1942-1952, 2018 | 37 | 2018 |
| Understanding the impact of multi-factorial composition on efficient loading of the stable ketoprofen nanoparticles on orodispersible films using Box-Behnken Design HG Shah, V Rathod, P Basim, B Gajera, RH Dave Journal of Pharmaceutical Sciences 111 (5), 1451-1462, 2022 | 23 | 2022 |
| Influence of processing methods on physico-mechanical properties of Ibuprofen/HPC-SSL formulation K Chaturvedi, BY Gajera, T Xu, H Shah, RH Dave Pharmaceutical development and technology 23 (10), 1108-1116, 2018 | 22 | 2018 |
| Formulation development and optimization of ibuprofen poloxamer melt granules using hydrophilic excipients BY Gajera, RP Dugar, RH Dave Br J Pharm Res 13 (6), 1-19, 2016 | 21 | 2016 |
| Investigating a novel hot melt extrusion-based drying technique to solidify an amorphous nanosuspension using design of experiment methodology BY Gajera, DA Shah, RH Dave Aaps Pharmscitech 19, 3778-3790, 2018 | 16 | 2018 |
| Hybridized nanoamorphous micellar dispersion using a QbD–DM3 linked rational product design strategy for ritonavir: A BCS IV drug V Rathod, WC Stagner, B Gajera, RV Haware International Journal of Pharmaceutics 588, 119727, 2020 | 11 | 2020 |
| Strategizing spray drying process optimization for the manufacture of redispersible indomethacin nanoparticles using quality-by-design principles V Rathod, B Gajera, A Pinninti, IA Mohammed, RH Dave AAPS PharmSciTech 24 (5), 133, 2023 | 2 | 2023 |
| To evaluate hot melt extruder as a novel technique to dry nanosuspension and develop a mechanistic understanding of polymeric factors influencing the stabilization of … BY Gajera Long Island University, The Brooklyn Center, 2018 | 2 | 2018 |
| Developing a formulation strategy coupled with PBPK modeling and simulation for the weakly basic drug albendazole H Shah, K Shah, B Gajera, RH Dave, DR Taft Pharmaceutics 15 (4), 1040, 2023 | 1 | 2023 |
| Development of a Precision Olfactory Delivery (POD®)-Olanzapine Drug-Device Product for Agitation KH Satterly, B Gajera, GJ Davies, H Lin, S Muppaneni, J Wright, K To, ... Western Journal of Emergency Medicine: Integrating Emergency Care with …, 2019 | 1 | 2019 |
| Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease JD Hoekman, KH Satterly, I Dashevsky, AR Das, SB Shrewsbury, ... US Patent App. 18/313,330, 2023 | | 2023 |
| Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's disease JD Hoekman, KH Satterly, I Dashevsky, AR Das, SB Shrewsbury, ... US Patent 11,690,819, 2023 | | 2023 |
| Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease JD Hoekman, KH Satterly, I Dashevsky, AR Das, SB Shrewsbury, ... US Patent 11,517,548, 2022 | | 2022 |
| Challenges in Oral Delivery of Nutraceuticals: From Formulation Scale-Up to Clinical Assessment K Chaturvedi, H Shah, B Gajera Nutraceutical Delivery Systems, 241-278, 2022 | | 2022 |
| ADMINISTRATION OF LEVODOPA AND DOPA DECARBOXYLASE INHIBITOR INTO THE RESPIRATORY TRACT FOR THE TREATMENT OF PARKINSON'S DISEASE JD Hoekman, KH Satterly, I DASHEVSKY, SB Shrewsbury, GJ DAVIES, ... | | 2022 |
| Preclinical Development of a Novel Carbidopa/Levodopa Precision Olfactory Delivery (POD (R)) Drug-Device Combination Product for the Treatment of OFF Episodes in Parkinson's … K Satterly, G Davies, B Gajera, J Wright, H Lin, S Muppaneni, K To, ... MOVEMENT DISORDERS 34, S81-S82, 2019 | | 2019 |
| Preclinical Development of a Novel Precision Olfactory Delivery (POD®)-L-dopa Drug-Device Combination Product for the Treatment of OFF Episodes in Parkinson’s Disease (P2. 8-049) K Satterly, G Davies, B Gajera, J Wright, H Lin, S Muppaneni, K To, ... Neurology 92 (15_supplement), P2. 8-049, 2019 | | 2019 |
